Progestogen receptor agonist - BayerAlternative Names: Progestin receptor agonist - Bayer
Latest Information Update: 06 Oct 2006
At a glance
- Originator Bayer
- Mechanism of Action Progesterone receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Postmenopausal osteoporosis
Most Recent Events
- 06 Oct 2006 Discontinued - Phase-I for Postmenopausal osteoporosis in Germany (unspecified route)
- 14 Feb 2001 Phase-I clinical trials for Postmenopausal osteoporosis in Germany (Unknown route)